TY - JOUR
T1 - Implementation of Obesity Science Into Clinical Practice
T2 - A Scientific Statement From the American Heart Association
AU - on behalf of the American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Hypertension; Council on the Kidney in Cardiovascular
AU - Laddu, Deepika
AU - Neeland, Ian J.
AU - Carnethon, Mercedes
AU - Stanford, Fatima C.
AU - Mongraw-Chaffin, Morgana
AU - Gibbs, Bethany Barone
AU - Ndumele, Chiadi E.
AU - Longenecker, Chris T.
AU - Chung, Misook L.
AU - Rao, Goutham
N1 - Publisher Copyright:
© 2024 American Heart Association, Inc.
PY - 2024/7/2
Y1 - 2024/7/2
N2 - Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Over the past decade, obesity science has evolved to improve knowledge of its multifactorial causes, identifying important biological causes and sociological determinants of obesity. Treatments for obesity have also continued to develop, with more evidence-based programs for lifestyle modification, new pharmacotherapies, and robust data to support bariatric surgery. Despite these advancements, there continues to be a substantial gap between the scientific evidence and the implementation of research into clinical practice for effective obesity management. Addressing barriers to obesity science implementation requires adopting feasible methodologies and targeting multiple levels (eg, clinician, community, system, policy) to facilitate the delivery of obesity-targeted therapies and maximize the effectiveness of guideline-driven care to at-need patient populations. This scientific statement (1) describes strategies shown to be effective or promising for enhancing translation and clinical application of obesity-based research; (2) identifies key gaps in the implementation of obesity science into clinical practice; and (3) provides guidance and resources for health care professionals, health care systems, and other stakeholders to promote broader implementation and uptake of obesity science for improved population-level obesity management. In addition, advances in implementation science that hold promise to bridge the know-do gap in obesity prevention and treatment are discussed. Last, this scientific statement highlights implications for health research policy and future research to improve patient care models and optimize the delivery and sustainability of equitable obesity-related care.
AB - Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Over the past decade, obesity science has evolved to improve knowledge of its multifactorial causes, identifying important biological causes and sociological determinants of obesity. Treatments for obesity have also continued to develop, with more evidence-based programs for lifestyle modification, new pharmacotherapies, and robust data to support bariatric surgery. Despite these advancements, there continues to be a substantial gap between the scientific evidence and the implementation of research into clinical practice for effective obesity management. Addressing barriers to obesity science implementation requires adopting feasible methodologies and targeting multiple levels (eg, clinician, community, system, policy) to facilitate the delivery of obesity-targeted therapies and maximize the effectiveness of guideline-driven care to at-need patient populations. This scientific statement (1) describes strategies shown to be effective or promising for enhancing translation and clinical application of obesity-based research; (2) identifies key gaps in the implementation of obesity science into clinical practice; and (3) provides guidance and resources for health care professionals, health care systems, and other stakeholders to promote broader implementation and uptake of obesity science for improved population-level obesity management. In addition, advances in implementation science that hold promise to bridge the know-do gap in obesity prevention and treatment are discussed. Last, this scientific statement highlights implications for health research policy and future research to improve patient care models and optimize the delivery and sustainability of equitable obesity-related care.
KW - AHA Scientific Statements
KW - evidence-based practice
KW - implementation science
KW - obesity
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85195219370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195219370&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000001221
DO - 10.1161/CIR.0000000000001221
M3 - Review article
C2 - 38766861
AN - SCOPUS:85195219370
SN - 0009-7322
VL - 150
SP - e7-e19
JO - Circulation
JF - Circulation
IS - 1
ER -